Skip to ContentSkip to Navigation
How to find us S.S. Gangadin

Publications

Tapering antipsychotic medication: practical considerations

Longitudinal clinical and functional outcome in distinct cognitive subgroups of first-episode psychosis: a cluster analysis

Reduced resting state functional connectivity in the hippocampus-midbrain-striatum network of schizophrenia patients

Simvastatin Augmentation for Patients With Early-Phase Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Placebo-Controlled Trial

The effect of prednisolone on symptom severity in schizophrenia: A placebo-controlled, randomized controlled trial

Prednisolone versus placebo addition in the treatment of patients with recent-onset psychotic disorder: a trial design

To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial

Atopy Increases Risk of Psychotic Experiences: A Large Population-Based Study

MRI investigation of immune dysregulation in schizophrenia

The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic Review

Read more

Press/media

El uso de simvastatina no tiene efecto en los síntomas de esquizofrenia y la función cognitiva